ganiMed does not only represent a rational synthesis in the signal analysis of cardiology, that is to say a combination of standard ECG diagnostics, the logical further development or evolutionary course of new analysis methods (prognostics), but also and in particular a consistent orientation based on partnership upon interactions with the researching pharmaceutical enterprises.